Nanoparticles made out of gold to cure eye diseases
A new study by a professor of the faculty of medicine at Université Laval suggests that the use of nanoparticles made out of gold could improve the effectiveness of eye disease treatments.
Professor Élodie Boisselier holds a patent for a technology that allows an ophthalmic drug to adhere to the mucous membrane of the eye thanks to the use of gold nanoparticles. This type of technology can improve the life of patients with cataracts, and with its post-surgical treatment.
Learn more about this new technology: https://bit.ly/3oHC1Gt
Posted on: Jun 28, 2021
UNIVERSITY OF TORONTO GLOBAL CHALLENGES, GLOBAL ENGINEERING:Connecting Latin America and Canada through engineering Do you ...
Posted on: Jun 3, 2021
Why Choose Canada? – University of Saskatchewan Do you want to create solutions to address some of the world’s critical ...
Posted on: May 18, 2021
Why Choose Canada? – University of Alberta Students from more than 150 countries worldwide choose the University of ...
Posted on: Apr 6, 2021
University of Waterloo: Connecting Imagination with Impact We would like to invite you to our next webinar where we will have ...
Posted on: Mar 25, 2021
Jun Yang, a material, mechanical and biomedical professor at Western University is working closely with a mechanical and ...
Posted on: Mar 15, 2021
The Dallaire Institute of Children, Peace and Security aims to address the problem of child soldiers around the world by ...
Posted on: Mar 8, 2021
Did you know a team of Canadian researchers is building a next-generation telescope capable of measuring light from the ...
Posted on: Feb 3, 2021
¡Paraguay@! Te recordamos que la primera convocatoria CALDO-BECAL para doctorados en Canadá sigue abierta hasta el próximo 28 ...
Posted on: Feb 2, 2021
¡Estudiantes, investigadores y profesionales uruguayos! Les queremos invitar a participar de nuestro próximo webinar. ...
Request a Contact
To request a contact from CALDO for support and additional information, please provide the information below.